Â鶹´«Ã½Ó³»­

Â鶹´«Ã½Ó³»­

Explore the latest content from across our publications
Join The Â鶹´«Ã½Ó³»­

Log In

Forgot Password?
Create New Account

Loading... please wait

2020 Annual Meeting | C267 - Â鶹´«Ã½Ó³»­ Blitz: Normal Pressure Hydrocephalus

Friday 05/01/20
08:00 AM - 09:00 AM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Â鶹´«Ã½Ó³»­ Blitz
Neill R. Graff-Radford, MD, FÂ鶹´«Ã½Ó³»­
Aging, Dementia, and Behavioral Neurology
Participants will recognize this is an uncommon disease. The practical way to start is to address the the possible causes of gait difficulty in a specific patient. The best diagnostic tests are a temporary shunt (large volume LP or external CSF drainage) and imaging findings. Complications from surgery are common. There are ways to decrease the complicatons and managed them non invasively. CSF biomarkers can be deceptive. There are several factors that play a role in the pathogenesis of this disease.
1.00 CME credit
Patient Care & Procedural Skills, Interpersonal and Communication Skills, Medical Knowledge, Practice-based Learning and Improvement
Intermediate
Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider
Case-based, Didactic
Event Timeline
08:00 AM - 08:30 AM Speaker A Clinical Approach to NPH
Neill R. Graff-Radford, MD, FÂ鶹´«Ã½Ó³»­
08:30 AM - 09:00 AM Speaker Imaging and NPH
David T. Jones, MD
Faculty Disclosures
Neill R. Graff-Radford, MD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Graff-Radford has received research support from Biogen. The institution of Dr. Graff-Radford has received research support from Lilly. The institution of Dr. Graff-Radford has received research support from Eisai. The institution of Dr. Graff-Radford has received research support from Biogen. Dr. Graff-Radford has received publishing royalties from a publication relating to health care.
David T. Jones, MD Dr. Jones has stock in Cephlodyne Neurotechnologies, Inc.. Dr. Jones has received intellectual property interests from a discovery or technology relating to health care.